Digital Transforming Pharma: Insights from Frontiers Health 2025 pharmaphorum caught up with Emre Ozcan (Merck Group) after his onstage session at Frontiers Health.
Digital The right AI for the right job, with Iya Khalil In a post-BIO virtual interview, Jonah Comstock speaks with Iya Khalil, VP and head of data, AI, and genome sciences at Merck & Co (MSD in Europe).
News Falling demand sees J&J scale back COVID-19 vaccine With demand for its COVID-19 vaccine decreasing, Johnson & Johnson (J&J) has begun
News NICE backs use of MSD's KEYTRUDA for triple-negative breast ... For the first time, patients in England with triple-negative breast cancer (TNBC) will be able to access immunotherapy at an earlier stage of their treatment journey, as Merck & Co/MSD'
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.